Company: FEAV
Filing Date: 2025-03-27
Form Type: 424B3
Source: 0001193125-25-065503
Chunk: 10

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-03-27
Form: 424B3
Chunk 10
---
.1 of the Australian Corporations Act, 2001 (Cth), we listed our common stock on The
Nasdaq Global Select Market (“Nasdaq”) and de-listed ABR from the

7

ASX in March 2022. In connection with a series of out-of-court restructuring transactions consummated in January
2024, we issued shares of our common stock and CHESS Depositary Interests, each representing an interest in one-tenth of a share of our common stock (“CDIs”), to ABR’s shareholders, and ABR
became our wholly owned subsidiary.

Our principal executive offices are located at 9329 Mariposa Road, Ste 210, Hesperia, CA 92344 and
our telephone number is (442) 221-0225. Our website address is http://www.5eadvancedmaterials.com. The information contained on, or that can be accessed through, our website is not incorporated by referenced
into this prospectus and does not constitute a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.

8

THE OFFERING

| Issuer | 5E Advanced Materials, Inc. |

| Shares of common stock that may be offered and sold from time to time by the Selling Stockholders named 
 herein                                                                                                  | 20,627,389 (the “Resale Shares”) of common stock, par value of $0.01 per share, consisting of (i) 13,586,524 shares of common stock issued to the Selling Stockholders on March 5, 2025 pursuant to an Exchange Agreement dated 
 January 14, 2025 between the Company and the Selling Stockholders (the “Exchange Agreement”), (ii) 1,408,173 shares of common stock issued to the Selling Stockholders on March 13, 2025 pursuant to a Securities Subscription  
 Agreement dated January 14, 2025 between the Company and the Selling Stockholders (the “Subscription Agreement”) and (iii) up to 5,632,692 shares of common stock issuable upon exercise of warrants issued to the Selling      
 Stockholders on March 13, 2025 pursuant to the Subscription Agreement.                                                                                                                                                          |

| Use of proceeds | We will not receive any of the proceeds from the sale of the Resale Shares by the Selling Stockholders. |

| Market for our common stock | Our common stock is listed on Nasdaq under the symbol “FE